Stem Cells for Acute Myocardial Infarction: Safety and Efficacy
Authors
Teguh Santoso, ; Idrus Alwi, ; Cynthia Retna Sartika, ; Cosphiadi Irawan, ; Dewi Wulandari, ; Ika Prasetya Wijaya, ; Eka Ginanjar, ; Elizabeth Merry Wintery, ; Mohamad Syahrir Azizi, ; Aw Tar Choon, ; Bayu Winata Putera, ; Yanni Dirgantara, ; Angliana, ; Ditta Kalyani Devi, ; Nadya Karina, ; Rima Haifa, ; Nabilla Farah Naura, ; Billy Yosua Costantin Pongajow, ; Marsya Nilam Kirana, ; Atikah Anwar Hasibuan,Author Biographies
is a specialist in internal medicine, especially in cardiovascular, and a cardiology specialist who provides various medical support services, including heart examinations, thoracic, and cardiovascular surgery. One of his practice locations is at Medistra Hospital in Jakarta. He pursued specialized education as a cardiovascular consultant in internal medicine in 1975, and in 1978, he completed his education as a heart and blood vessel specialist. He then continued his Doctor of Philosophy degree at Erasmus Universiteit Rotterdam in 1980. He is registered as a member of the Indonesian Association of Specialists in Internal Medicine and the Indonesian Association of Cardiovascular Specialists.
is a distinguished Cardiology Consultant at the Universitas Indonesia and is recognized for his exceptional expertise and significant contributions to the field of interventional cardiology and stem cell research. Idrus Alwi embarked on his academic journey at Universitas Indonesia, graduating as a specialist in internal medicine in 1996 and as a cardiology consultant in 2001. His passion for advancing medical knowledge led him to pursue a PhD at the same institution, which he completed in 2006. In 2012, with an unwavering commitment to academic excellence and patient care, Idrus Alwi was appointed as a Professor of Internal Medicine at Universitas Indonesia, a position he continues to hold with dedication and distinction. Throughout his illustrious career, Idrus Alwi has demonstrated a profound dedication to advancing the field of interventional cardiology and stem cell applications, pioneering novel techniques and methodologies that have been instrumental in exploring innovative treatment modalities.
completed her doctoral degree in the Faculty of Medicine at Universitas Hasanuddin in 2009. She has engaged in a multifaceted and distinguished career and is also actively involved in various professional organizations and committees, which contribute significantly to the fields of atherosclerosis and vascular diseases. Her notable affiliations include memberships in the Persatuan Atherosclerosis dan Penyakit Vascular Indonesia (PAPVI), the International Society of Stem Cell Research (ISCCR), the International Society of Cell & Gene Therapy (ISCT), and the International Society of Extracellular Vesicles (ISEV). Cynthia Retna Sartika is also a key participant in the Konsorsium Pengembangan Sel Punca and serves on the Adhoc Team for Health Minister Regulations (Tim Adhoc Peraturan Menteri Kesehatan–Permenkes). Additionally, she is also actively involved in the Asosiasi Sel Punca Indonesia (ASPI) or Indonesia Stem Cell Association and contributes her expertise to the team, specializing in the Good Manufacturing Practice for Pharmaceuticals (Tim Ahli Cara Pembuatan Obat yang Baik—CPOB). As a member of the Asian Cellular Therapy Organization (ACTO) and the Research and Networking Commission at the Committee for Stem Cell and Cell Development, Ministry of Health of the Republic of Indonesia, Cynthia Retna Sartika demonstrates a strong commitment to advancing scientific research and healthcare practices in Indonesia.
a distinguished medical professional, completed his medical education at Universitas Indonesia. He further pursued specialized training in internal medicine through the Internal Medicine Specialist Education Program at the same institution. In 2011, he achieved a subspecialist designation in Internal Medicine, demonstrating his commitment to excellence in his field. In 2015, Cosphiadi Irawan earned a doctorate from the Universitas Indonesia, solidifying his academic prowess and dedication to advancing medical knowledge. Currently serving as a Clinical Educator at the Faculty of Medicine, Internal Medicine Study Program, he holds the esteemed position of Lector. Cosphiadi Irawan’s expertise lies in the realm of Hematology-Oncology, where he contributes significantly as a staff member in the Hematology-Oncology Division within the Department of Internal Medicine at the Faculty of Medicine, Universitas Indonesia, and Dr. Cipto Mangunkusumo National General Hospital (FKUI/RSCM). His professional journey reflects a remarkable commitment to education and clinical excellence.
earned her doctoral degree from the Universitas Indonesia in 2022. Currently, she serves in the Department of Clinical Pathology at the Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo National General Hospital (FKUI/RSCM). She holds the position of Doctor in Charge at Prodia Stemcell Indonesia (ProSTEM).
completed his medical education at Universitas Indonesia in 1992. He then continued his specialist education in internal medicine at the Specialist Doctor Education Program at Universitas Indonesia and graduated in 2003. In 2011, Ika Prasetya Wijaya completed his subspecialist education in Internal Medicine at the same university. Now, he serves as a clinical educator at the Faculty of Medicine, Internal Medicine Study Program at Universitas Indonesia, where his current functional position is as a lector. He is an expert in the field of cardiology. He is listed as a member of the staff of the Cardiology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo National General Hospital (FKUI/RSCM). He is a member of the Greater Jakarta Branch of the Indonesian Society of Internal Medicine (PAPDI).
earned his doctorate from the Universitas Indonesia in 2019. With extensive experience as a clinician and academician, Ginanjar has made significant contributions as the Head of the Integrated Heart Service (Pelayanan Jantung Terpadu–PJT) at Dr. Cipto Mangunkusumo National General Hospital (RSCM) from 2014 to 2023. Serving as a Specialist in Internal Medicine and Consultant Cardiologist at the same institution, he honed his skills through an Interventional and Clinical Cardiology Fellowship Training Program at the National Heart Institute of Malaysia in 2012. His outstanding expertise is recognized through fellowships at leading organizations, such as the Indonesian Society of Internal Medicine (FINASIM), the American College of Physicians (FACP), and the International College of Angiology (FICA). Actively engaged in professional associations, such as PAPDI (Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia/Indonesian Society of Internal Medicine) and IKKI (Ikatan Keseminatan Kardioserebrovaskular Indonesia/Indonesian Cardiocerebrovascular Society), Eka Ginanjar demonstrates his dedication to advancing cardiovascular care in Indonesia.
is a specialist in internal medicine who provides various medical services, such as internal medicine consultation and immunology consultation. One of her practice locations is Medistra Hospital in Jakarta. She completed her specialization degree in Internal Medicine at the Universitas Indonesia. She is registered as a member of the Indonesian Association of Specialists in Internal Medicine.
completed his education at the University of Indonesia in 2019. He has established a noteworthy presence in the field of cardiovascular imaging. As a dedicated member of the Asian Pacific Society of Cardiovascular Imaging (ASCI), he actively contributes to advancing knowledge and practices in cardiovascular health. Additionally, he holds membership in the American Society of Echocardiography (ASE), reflecting his commitment to staying at the forefront of international developments in cardiovascular imaging. He has been honored with a fellowship in the International College of Angiology (ICA), denoted by the prestigious title FICA. Further showcasing his recognition within the medical community, Mohamad Syahrir Azizi holds fellowships in PAPDI (Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia/Indonesian Society of Internal Medicine) and FINASIM (Fellowship of Indonesian Society of Internal Medicine). He is also an esteemed member of IDI (Ikatan Dokter Indonesia/Indonesian Medical Association) and actively participates in the IKKI (Ikatan Keseminatan Kardioserebrovaskular IndonesiaIndonesian Cardiocerebrovascular Society), emphasizing his dedication to the advancement of cardiovascular care and expertise in Indonesia.
is an expert in the field of medicine and clinical chemistry. He completed his medical education at the University of Malaya Medical School, followed by a master's degree in public policy at Harvard-NUS. He underwent training in internal medicine at Singapore General Hospital and King's College Hospital & Medical School. Additionally, he pursued training in clinical chemistry at the Department of Pathology & Laboratory Medicine at the Hospital of the University of Pennsylvania. Aw Tar Choon is the Director of Chemical Pathology at the Department of Laboratory Medicine at Changi General Hospital and the Head of Biochemistry Service at Seng Kang Hospital. Despite his busy schedule, he holds academic appointments as a Clinical Senior Lecturer (Medicine) at the National University of Singapore (NUS) and Clinical Professor (Pathology) at Duke-NUS Graduate Medical School. He was elected as Fellow of the Royal College of Physicians of Edinburgh (1999), Fellow of the Chapter of Pathologists Academy of Medicine Singapore (2004), and International Fellow College of American Pathologists (2020). His professional qualifications include a Board Certification in Internal Medicine from NUS and The Royal College of Physicians (UK), as well as a Sub-specialty Board Certification in Chemical Pathology from the Royal College of Pathologists of Australasia. He is a member of the Royal College of Physicians in Edinburgh and Ireland and The Academy of Medicine Singapore.
Additionally, he is on the Executive Council of several global scientific institutions, including the Singapore Association of Clinical Biochemists, the Singapore Society of Pathology, and The Endocrine & Metabolic Society of Singapore. He has published over 200 journal articles, including 17 on Covid-19, and delivered over 370 lectures in 25 countries, including 11 webinars on Covid-19. He is a recipient of several distinguished national and international awards. He also serves on the editorial boards of several journals, including Nature Scientific Reports.
completed his bachelor's degree in pharmacy, followed by a pharmacist profession at Universitas Padjajaran. He pursued his postgraduate education at Hasanuddin University, focusing on Biomedics, specifically a concentration in Clinical Chemistry. His research focused on the role of visfatin obestatin in the proliferation of pancreatic beta cells and was published in the Indonesian Biomedical Journal. He pursued his doctoral studies at the Faculty of Medicine, Hasanuddin University. His dissertation, Stem Cell Dynamics in Stroke Patients who have undergone Intra-Arterial Heparia Flushing explores hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs), endothelial progenitor cells (EPCs), and very small embryonic like cells (VSELs). Bayu Winata Putera currently serves as the Operational Manager at Prodia StemCell Indonesia.
completed her master’s degree at Universitas Padjajaran with a research focus on mesenchymal stem cells derived secretome comparison between umbilical cord vs adipose tissue. Currently excelling as the Production Laboratory Supervisor at Prodia StemCell Indonesia, she brings her expertise and leadership to the organization. Yanni commits to advancing scientific knowledge, coupled with her adeptness in overseeing production processes within the stem cell laboratory.
pursued her doctoral studies at the Faculty of Pharmacy, Universitas Padjajaran. Her groundbreaking dissertation, Effect of Mesenchymal Stem Cell-Derived Conditioned Medium Co-cultured with Mononuclear Cell from Type 2 Diabetes Mellitus Patient on Insulin Resistance Model HepG2 Cell, exemplifies her commitment to advancing scientific knowledge. Angliana currently applies her expertise as the Quality and Development Supervisor at Prodia StemCell Indonesia.
achieved her master's degree at Universitas Padjajaran with a research focus on the effect of UC-MSC and CM UC-MSC administration on IL, MMP, and COMP levels in osteoarthritis SF-MSC. Currently, she serves as the Marketing Therapy Supervisor at Prodia StemCell Indonesia. Her academic dedication and research experience uniquely position her in a crucial capacity within the organization, overseeing marketing strategies related to therapy.
completed her biotechnology studies at Al Azhar University in 2017. She has been working for four years in the field of stem cells as an advisor for stem cell therapy, mainly focusing on stem cells in the areas of the heart and neurology.
completed her bachelor's degree in biology at Universitas Indonesia. She pursued her master’s degree at Universitas Padjadjaran, focusing on Pharmacy, specifically a concentration in Clinical Pharmacy. Her thesis focused on the role of dendritic cells derived from autologous peripheral blood or allogeneic umbilical cord blood in T cells of nasopharyngeal carcinoma patients. She is an esteemed member of various professional associations, including the Asosiasi Sel Punca Indonesia (ASPI/Indonesian Stem Cell Association), the International Society of Cell & Gene Therapy (ISCT), the International Society of Extracellular Vesicles (ISEV), and the Asian Cellular Therapy Organization (ACTO). These affiliations underscore her commitment in being abreast of cutting-edge developments in her field. Presently, Rima Haifa holds the position of Research-Based Therapy Supervisor at Prodia StemCell Indonesia.
is a Master of Science student at University College London studying the Manufacture and Commercialization of Stem Cell and Gene Therapies. She received a full-ride scholarship for her master's study from the Indonesia Endowment Funds for Education (LPDP), Ministry of Finance. Previously, she was an Advisor for Stem Cell Therapy at PT. Prodia Stem Cell Indonesia for 2,5 years managing stem cell clinical trials and scientific publications. Several of her writings have been published in cytotherapy, the official journal of the International Society of Cell and Gene Therapy (ISCT).
graduated with a bachelor's degree in biotechnology from the University of Pelita Harapan. In 2023, he garnered recognition through the Student Creativity Program-Scientific Article, showcasing his commitment to academic excellence. Additionally, Billy brings practical experience to the table, having served as an intern in the Research-Based Therapy Department at Prodia StemCell Indonesia in 2022.
holds a Master of Science in Stem Cell Engineering for Regenerative Medicine from the University of Glasgow. With expertise in stem cell research and biomaterials, her background aligns well with her previous role as a scientist and advisor for stem cell therapy at PT. Prodia StemCell Indonesia. Marsya actively contributes to scientific discourse and innovation in her areas of specialization.
earned her bachelor's degree in biology from Universitas Indonesia. She currently serves as the Advisor for Stem Cell Therapy at PT Prodia StemCell Indonesia, focusing on internal and skin diseases. In addition to her advisory role, she has responsibilities related to toll manufacturing. Several of her writings have been published in Cytotherapy, the official journal of the International Society for Cell and Gene Therapy (ISCT).
Downloads
Pages
Published
Series
Categories
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


























